SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Regeneron Pharmaceuticals -- Ignore unavailable to you. Want to Upgrade?


To: Biotechwantabe who wrote (3541)4/24/2024 11:32:03 PM
From: Miljenko Zuanic  Read Replies (1) | Respond to of 3557
 
I think that ALNY opted out for those two candidates, and probably for few more!!!???
So, is REGN STUPID to waste $$$ on those programs/candidates???

They (REGN SCIENTIFIC team with Yan as leader), in past, MADE INCREDIBLY STUPID DECISION when abandoned the ANG-2/VEGF combo targets (inability to generate DUAL Abs???) for further development for nAMD/DME! So, their CREDENTIALS went down to ZERO. Will their credentials now go negative???
Cheers, (lasted from 1996)



To: Biotechwantabe who wrote (3541)6/12/2024 1:32:39 PM
From: Biotechwantabe  Respond to of 3557
 
Aln-ang3

Another trial that regeneron is running